(1)
Bettuzzi, T.; Bachelez, H.; Beylot-Barry, M.; Arlégui, H.; Paul, C.; Viguier, M.; Mahé, E.; Beneton, N.; Jullien, D.; Richard, M.-A.; Joly, P.; Tubach, F.; Dupuy, A.; Sbidian, E.; Chosidow, O. Evolution of Drug Survival With Biological Agents and Apremilast Between 2012 and 2018 in Patients With Psoriasis from the PsoBioTeq Cohort. Acta Derm Venereol 2022, 102, adv00665.